Therapy News and Research

RSS
Scientists discover biological marker that may help identify patients’ response to antidepressants

Scientists discover biological marker that may help identify patients’ response to antidepressants

Blood levels of IL-6 protein may also serve as red flag for relapse in schizophrenia patients

Blood levels of IL-6 protein may also serve as red flag for relapse in schizophrenia patients

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Adalimumab effective in maintaining remission in pediatric patients with Crohn's disease

Adalimumab effective in maintaining remission in pediatric patients with Crohn's disease

Exercise hope for drug-resistant hypertension

Exercise hope for drug-resistant hypertension

Vorinostat drives HIV from hiding

Vorinostat drives HIV from hiding

Pendrin a possible new target for diuretic therapy

Pendrin a possible new target for diuretic therapy

Boric acid treatment equals best practice for otitis media

Boric acid treatment equals best practice for otitis media

‘Chicken Wing’ clue to stroke risk in atrial fibrillation

‘Chicken Wing’ clue to stroke risk in atrial fibrillation

Wellcome Trust grants £1.6 million Translation Award for development of more effective radiotherapy

Wellcome Trust grants £1.6 million Translation Award for development of more effective radiotherapy

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

Biden seeks to allay veterans' concerns about benefits

Biden seeks to allay veterans' concerns about benefits

Novel multireceptor-targeted somatostatin analogue found effective against neuroendocrine tumors

Novel multireceptor-targeted somatostatin analogue found effective against neuroendocrine tumors

New research center to expedite study of gene transfer approach

New research center to expedite study of gene transfer approach

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Scientists identify key factor that drives resistance to cancer drug

Scientists identify key factor that drives resistance to cancer drug

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.